EVA Pharma Signs a Voluntary Licensing Agreement with Gilead to Increase Access to Lenacapavir in 120 Countries with High Human Immunodeficiency Virus (HIV) Incidence and Limited Resources
Views: 39 PRESS RELEASE EVA Pharma Signs a Voluntary Licensing Agreement with Gilead to Increase Access to Lenacapavir in 120 Countries with High Human Immunodeficiency Virus (HIV) Incidence and Limited Resources Under this royalty-free voluntary licensing agreement EVA Pharma will manufacture and supply Lenacapavir active pharmaceutical ingredient and finished pharmaceutical product Access Multimedia Content CAIRO, […]